(Q38112349)

29 August 2017

Myocardial energetics in heart failure (English)

1 reference

29 August 2017

0 references

Alexander Nickel

1

1 reference

29 August 2017

Joachim Löffler

series ordinal

2

1 reference

29 August 2017

Christoph Maack

series ordinal

3

1 reference

29 August 2017

6 June 2013

1 reference

Basic Research in Cardiology

29 August 2017

1 reference

29 August 2017

108

1 reference

29 August 2017

4

1 reference

29 August 2017

358

1 reference

https://scigraph.springernature.com/pub.10.1007/s00395-013-0358-9

29 August 2017

0 references

cites work

Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

The heart metabolism: pathophysiological aspects in ischaemia and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

The mitochondrial origin of postischemic arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Ferric carboxymaltose in patients with heart failure and iron deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Redox-optimized ROS balance: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Role of sodium-calcium exchanger in modulating the action potential of ventricular myocytes from normal and failing hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Cardiac energy metabolism homeostasis: role of cytosolic calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Domestication of the cardiac mitochondrion for energy conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Mitochondria, oxidants, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Effects of perhexiline on myocardial deformation in patients with ischaemic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Oxygen free radicals and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Altered cardiac myocyte Ca regulation in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Calcium, ATP, and ROS: a mitochondrial love-hate triangle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Metabolic remodeling in the hypertrophic heart: fuel for thought

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Mitofusin 2-containing mitochondrial-reticular microdomains direct rapid cardiomyocyte bioenergetic responses via interorganelle Ca(2+) crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Ca2+ dynamics in the mitochondria - state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Control and regulation of integrated mitochondrial function in metabolic and transport networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Structural and functional features and significance of the physical linkage between ER and mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Cardiac anaplerosis in health and disease: food for thought

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Functional consequences of endothelial nitric oxide synthase uncoupling in congestive cardiac failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

SR and mitochondria: calcium cross-talk between kissing cousins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Effect of beta-blockers on free radical-induced cardiac contractile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Substrate utilization by the failing human heart by direct quantification using arterio-venous blood sampling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Damage to mitochondrial complex I during cardiac ischemia reperfusion injury is reduced indirectly by anti-anginal drug ranolazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Mitochondria-Targeted Antioxidant MitoQ 10 Improves Endothelial Function and Attenuates Cardiac Hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

The role of the mitochondrial permeability transition pore in heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Beta-blocker use in systolic heart failure and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Identification and functional expression of the mitochondrial pyruvate carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Increased uncoupling protein 3 content does not affect mitochondrial function in human skeletal muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

The contribution of reactive oxygen species and p38 mitogen-activated protein kinase to myofilament oxidation and progression of heart failure in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

HDAC4 controls histone methylation in response to elevated cardiac load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Is depressed myocyte contractility centrally involved in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Energy metabolism in heart failure and remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Is the failing heart energy starved? On using chemical energy to support cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Ranolazine for the treatment of heart failure with preserved ejection fraction: background, aims, and design of the RALI-DHF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Iron deficiency: an ominous sign in patients with systolic chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Elevated cytosolic Na+ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Interplay of defective excitation-contraction coupling, energy starvation, and oxidative stress in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Glucose metabolism and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Mechanisms of reduced mitochondrial Ca2+ accumulation in failing hamster heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Modulating fatty acid oxidation in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Enhancing mitochondrial Ca2+ uptake in myocytes from failing hearts restores energy supply and demand matching

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Measuring local gradients of intramitochondrial [Ca(2+)] in cardiac myocytes during sarcoplasmic reticulum Ca(2+) release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Chronic creatine kinase deficiency eventually leads to congestive heart failure, but severity is dependent on genetic background, gender and age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Elevated cytosolic Na+ decreases mitochondrial Ca2+ uptake during excitation-contraction coupling and impairs energetic adaptation in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Endogenous activation of mitochondrial KATP channels protects human failing myocardium from hydroxyl radical-induced stunning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Excitation-contraction coupling and mitochondrial energetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

The spatial pattern of atrial cardiomyocyte calcium signalling modulates contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1α and upregulation of peroxisome proliferator-activated receptor-α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Regulation of the human cardiac mitochondrial Ca2+ uptake by 2 different voltage-gated Ca2+ channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Regulation of intracellular and mitochondrial sodium in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Uncoupling proteins in human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Novel aspects of excitation-contraction coupling in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

The failing heart--an engine out of fuel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Modulation of mitochondrial function by hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Mitochondrial Ca2+ uptake: tortoise or hare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Mitochondrial ion channels: gatekeepers of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

The metabolic vicious cycle in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

The adrenergic-fatty acid load in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

NCLX is an essential component of mitochondrial Na+/Ca2+ exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

MICU1 encodes a mitochondrial EF hand protein required for Ca(2+) uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Calcium concentration and movement in the ventricular cardiac cell during an excitation-contraction cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Microdomains of intracellular Ca2+: molecular determinants and functional consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Cardiac metabolism in myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Mitochondria in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Cardiac system bioenergetics: metabolic basis of the Frank-Starling law.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Redox signaling in cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Intracoronary pyruvate in cardiogenic shock as an adjunctive therapy to catecholamines and intra-aortic balloon pump shows beneficial effects on hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

An alternative function for human uncoupling protein 3: protection of mitochondria against accumulation of nonesterified fatty acids inside the mitochondrial matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Targeting antioxidants to mitochondria: a new therapeutic direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Animal and human studies with the mitochondria-targeted antioxidant MitoQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Orphaned ryanodine receptors in the failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Diastolic dysfunction and arrhythmias caused by overexpression of CaMKIIδ(C) can be reversed by inhibition of late Na(+) current

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Creatine kinase-deficient hearts exhibit increased susceptibility to ischemia-reperfusion injury and impaired calcium homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Myocardial substrate metabolism in the normal and failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

MitoQ administration prevents endotoxin-induced cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Creatine--a dispensable metabolite?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-N-methyltransferase-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Histone demethylation by a family of JmjC domain-containing proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Using metabolomics to assess myocardial metabolism and energetics in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Uncoupling protein-2 modulates myocardial excitation-contraction coupling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Metabolic remodelling in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Muscle creatine kinase-deficient mice. I. Alterations in myofibrillar function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Mitochondrial impairment contributes to cocaine-induced cardiac dysfunction: Prevention by the targeted antioxidant MitoQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Reactive oxygen species-activated Ca/calmodulin kinase IIδ is required for late I(Na) augmentation leading to cellular Na and Ca overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Inherited Cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

ATP flux through creatine kinase in the normal, stressed, and failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Calcium entry via Na/Ca exchange during the action potential directly contributes to contraction of failing human ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Lipotoxicity in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

The antianginal agent ranolazine is a weak inhibitor of the respiratory complex I, but with greater potency in broken or uncoupled than in coupled mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Effects of perhexiline-induced fuel switch on the cardiac proteome and metabolome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

The role of oxidants and free radicals in reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Elevated Levels of 8-iso-Prostaglandin F 2α in Pericardial Fluid of Patients With Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

Adverse bioenergetic consequences of Na+-Ca2+ exchanger-mediated Ca2+ influx in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-013-0358-9

10.1007/S00395-013-0358-9

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

0 references

1 reference